---
title: "RED SUN today conducted a block trade at a discount, with 12.98 million shares traded, totaling 88.0044 million yuan"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/256344679.md"
description: "On September 8th, RED SUN had a block trade of 12.98 million shares, with a transaction amount of 88.0044 million yuan, accounting for 23.85% of the total transaction amount for the day. The transaction price was 6.78 yuan, which is a discount of 2.02% compared to the market closing price of 6.92 yuan"
datetime: "2025-09-08T08:49:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/256344679.md)
  - [en](https://longbridge.com/en/news/256344679.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/256344679.md)
generator: "portal-rs"
---

# RED SUN today conducted a block trade at a discount, with 12.98 million shares traded, totaling 88.0044 million yuan

On September 8th, RED SUN had a block trade of 12.98 million shares, with a transaction amount of 88.0044 million yuan, accounting for 23.85% of the total transaction amount for the day. The transaction price was 6.78 yuan, which is a discount of 2.02% compared to the market closing price of 6.92 yuan

### Related Stocks

- [000525.CN](https://longbridge.com/en/quote/000525.CN.md)

## Related News & Research

- [Solar Innovation Reports Regulatory Notice on Significant Shareholding Change](https://longbridge.com/en/news/296636597.md)
- [REG - Cerillion PLC - TR-1 Notification](https://longbridge.com/en/news/296370992.md)
- [Red States Are Killin’ It With Their Solar Factories](https://longbridge.com/en/news/296689122.md)
- [13:49 ETVascarta Outlines Proposed Mechanistic Link Between VAS-101's (Vasceptor®) Vascular and Red Blood Cell Effects in Sickle Cell Disease](https://longbridge.com/en/news/296524035.md)
- [Dovre Group H1 2026 operating loss narrows to EUR 1 million; net sales rise 22.2% to EUR 1.1 million](https://longbridge.com/en/news/296462184.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**